- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT02276404
Preoperative Relaxation Training and Acupuncture to Minimize Perioperative Symptoms in Breast Cancer Patients
13 juni 2019 uppdaterad av: Silke Lange, Universität Duisburg-Essen
Entspannung Und Akupunktur Zur Reduktion Perioperativer Symptome Bei Brustkrebspatientinnen- Eine Randomisiert-kontrollierte Interventionsstudie im Kontext Einer Integrativ Onkologischen Versorgung (EARpeS)
Breast cancer surgery is associated with presurgical psychological distress and clinically significant side effects including postsurgical pain, nausea and fatigue.
A few studies have examined how to intervene to assist women undergoing breast cancer surgery.
For example presurgical hypnosis has been proven to decrease side effects and even intraoperative anesthesia use.
Besides the more psychologically based interventions there are a few studies suggesting positive effects of acupuncture on pain, anxiety and nausea in surgery patients.This study aims to investigate whether a presurgical relaxation training, acupuncture treatment or a combination of both therapies is able to reduce presurgical psychological distress an postsurgical side effects in breast cancer patients in comparison to usual care.
Studieöversikt
Status
Avslutad
Betingelser
Intervention / Behandling
Studietyp
Interventionell
Inskrivning (Faktisk)
120
Fas
- Inte tillämpbar
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
-
Essen, Tyskland, 45136
- Department of Senology, Kliniken Essen-Mitte
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
18 år till 75 år (Vuxen, Äldre vuxen)
Tar emot friska volontärer
Nej
Kön som är behöriga för studier
Kvinna
Beskrivning
Inclusion criteria:
- clinically proven breast cancer with an indication for breast conserving surgery with max. 50% volume reduction
- physical and psychological ability to take part in relaxation training
Exclusion criteria:
- serious psychiatric disorder
- to time span to surgery shorter than 2 weeks or longer than 20 weeks
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
---|---|
Experimentell: relaxation training
Each participant of the experimental group 1 receives 2 one-hour sessions of guided relaxation training prior to surgery.
|
The relaxation sessions comprise an introduction in 3 relaxation techniques conducted by a mind-body therapist: "Body Scan", mindfulness meditation and imagination.
Patients also receive a CD with different relaxation exercises and the instruction to exercise daily at home for at least 15 minutes.
|
Experimentell: acupuncture
Each participant of the experimental group 2 receives 3 acupuncture treatments with a semi-standardized acupoint scheme: once a week over 2 weeks and the day before surgery.
|
The acupuncture treatment comprises needling of 6 standardized acupoints: Pericardium 6, Stomach 36, Large intestine 4, Spleen/Pancreas 10, Dumai 20, Liver 3, Shenmen.
Additional points can be chosen individual.
|
Experimentell: relaxation training and acupuncture
Each patient of the experimental group 3 receives 3 acupuncture treatments with a semi-standardized acupoint scheme and 2 one-hour sessions of guided relaxation training prior to surgery.
|
The relaxation sessions comprise an introduction in 3 relaxation techniques conducted by a mind-body therapist: "Body Scan", mindfulness meditation and imagination.
Patients also receive a CD with different relaxation exercises and the instruction to exercise daily at home for at least 15 minutes.
The acupuncture treatment comprises needling of 6 standardized acupoints: Pericardium 6, Stomach 36, Large intestine 4, Spleen/Pancreas 10, Dumai 20, Liver 3, Shenmen.
Additional points can be chosen individual.
|
Inget ingripande: usual care
Patients receive usual senological treatment
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
presurgical psychological distress
Tidsram: expected average of 13 days
|
Measured by 100mm visual analog scale 1 day pre surgery
|
expected average of 13 days
|
postsurgical pain
Tidsram: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
---|---|---|
postsurgical psychological distress
Tidsram: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
postsurgical psychological distress
Tidsram: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
postsurgical pain
Tidsram: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
postsurgical nausea
Tidsram: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
postsurgical nausea
Tidsram: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
postsurgical fatigue
Tidsram: expected average of 15 days
|
Measured by 100mm visual analog scale 1 day post surgery
|
expected average of 15 days
|
postsurgical fatigue
Tidsram: expected average of 21 days
|
Measured by 100mm visual analog scale 1 week post surgery
|
expected average of 21 days
|
intraoperative analgesia use
Tidsram: expected average of 14 days
|
intraoperative analgesia use is taken from operative logs
|
expected average of 14 days
|
intraoperative anesthesia use
Tidsram: expected average of 14 days
|
intraoperative anesthesia use is taken from operative logs
|
expected average of 14 days
|
postoperative analgesia use
Tidsram: expected average of 15 days
|
postoperative analgesia use is taken from medical records
|
expected average of 15 days
|
immunemodulation
Tidsram: expected average of 14 days
|
natural killer cell activity is measured at begin of surgery
|
expected average of 14 days
|
immunemodulation
Tidsram: expected average of 14 days
|
natural killer cell activity is measured at end of surgery
|
expected average of 14 days
|
Number of patients with adverse events
Tidsram: expected average of 21 days
|
Number of patients with adverse events are measured one week post surgery
|
expected average of 21 days
|
presurgical psychological distress
Tidsram: expected average of 13 days
|
Measured by Profile of Mood States (POMS) 1 day pre surgery
|
expected average of 13 days
|
postsurgical psychological distress
Tidsram: expected average of 15 days
|
Measured by Profile of Mood States (POMS) 1 day post surgery
|
expected average of 15 days
|
postsurgical psychological distress
Tidsram: expected average of 21 days
|
Measured by Profile of Mood States (POMS) 1 week post surgery
|
expected average of 21 days
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Sponsor
Utredare
- Studiestol: Gustav J. Dobos, Prof, Chair of Complementary and Integrative Medicine, Universitay of Duisburg-Essen, Germany
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart (Faktisk)
1 november 2014
Primärt slutförande (Faktisk)
1 november 2018
Avslutad studie (Faktisk)
1 november 2018
Studieregistreringsdatum
Först inskickad
21 oktober 2014
Först inskickad som uppfyllde QC-kriterierna
27 oktober 2014
Första postat (Uppskatta)
28 oktober 2014
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
14 juni 2019
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
13 juni 2019
Senast verifierad
1 juni 2019
Mer information
Termer relaterade till denna studie
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- 14-5778-BO
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .
Kliniska prövningar på Bröstneoplasmer
-
Tianjin Medical University Cancer Institute and...Guangxi Medical University; Sun Yat-sen University; Chinese PLA General Hospital och andra samarbetspartnersAvslutadDen kliniska tillämpningsguiden för Conebeam Breast CTKina
-
ETOP IBCSG Partners FoundationAvslutadBreast Cancer Invasive NosItalien
-
Spanish Breast Cancer Research GroupHoffmann-La Roche; Roche Farma, S.AAvslutadBreast Cancer Invasive NosSpanien
-
Pomeranian Medical University SzczecinMaria Sklodowska-Curie National Research Institute of Oncology; Regional...OkändBRCA1-mutation | Breast Cancer Invasive NosPolen
-
University Health Network, TorontoAvslutadBreast Cancer Invasive Nos | Primär invasiv bröstcancerKanada
-
Novartis PharmaceuticalsAvslutadMetastaserad bröstcancer (MBC) | Locally Advance Breast Cancer (LABC)Storbritannien, Spanien
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)AvslutadMetastatisk malign neoplasm | Ooperbar malign neoplasm | Avancerad malign neoplasmFörenta staterna
-
Massachusetts General HospitalRekryteringMalign neoplasm | Benign neoplasmFörenta staterna
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, inte rekryterandeMetastatisk malign neoplasm | Avancerad malign neoplasm | Återkommande malign neoplasm | Refraktär malign neoplasm | Lokalt avancerad malign neoplasmFörenta staterna
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Aktiv, inte rekryterandeMalign neoplasm | Metastatisk malign neoplasm | Avancerad malign neoplasm | Återkommande malign neoplasm | Lokalt avancerad malign neoplasmFörenta staterna
Kliniska prövningar på relaxation training
-
Trinitas Comprehensive Cancer CenterAptium Oncology Research NetworkOkänd
-
Eduardo Fonseca PedreroPsicofundación: Fundación Española para Promoción, Desarrollo Científico... och andra samarbetspartnersRekryteringDepressiv sjukdom | Emotionell störning | Ångestsyndrom | Känslomässiga problemSpanien
-
Massachusetts General HospitalMarino FoundationAvslutadPåfrestningFörenta staterna
-
University of California, San FranciscoAvslutad
-
Massachusetts General HospitalAvslutadIrritabel tarmsyndrom | Inflammatorisk tarmsjukdomFörenta staterna
-
University of Sao PauloAvslutad
-
Hacettepe UniversityAvslutadMultipel skleros, skov-remitterande | Trötthetssyndrom, kronisk | Smärta, kronisk | KinesiofobiKalkon
-
Massachusetts General HospitalThe Children's Tumor FoundationAvslutadNeurofibromatos | Neurofibromatos 2 | Schwannomatos | Neurofibromatos IFörenta staterna
-
Massachusetts General HospitalOkändSmärta | Kronisk smärta | Fysisk aktivitetFörenta staterna
-
Massachusetts General HospitalThe Rappaport Foundation; The Claflin Distinguished Scholar AwardsHar inte rekryterat ännuVon Hippel-Lindaus sjukdom | Genetisk störningFörenta staterna